妇产科指南

订阅

MedSci主页 / 所有栏目 / 妇产科指南

2019 ISUOG实践指南：胎儿生物学和成长的超声评估

2019-06-08 国际妇产科超声学会 Ultrasound Obstet Gynecol. 2019 Jun;53(6):715-723.

胎儿超声评估

2019年6月，国际妇产科超声学会(ISUOG)发布了胎儿生物学和成长的超声评估指南，主要目的是为胎儿的生物学评估以及胎儿生长障碍的评估进行指导。

中文标题：

2019 ISUOG实践指南：胎儿生物学和成长的超声评估

英文标题：

ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth.

发布机构：

国际妇产科超声学会

发布日期：

2019-06-08

简要介绍：

2019年6月，国际妇产科超声学会(ISUOG)发布了胎儿生物学和成长的超声评估指南，主要目的是为胎儿的生物学评估以及胎儿生长障碍的评估进行指导。 

拓展指南：与胎儿超声相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 ISUOG实践指南：胎儿生物学和成长的超声评估)] GetToolGuiderByIdResponse(projectId=1, id=a2a391c001ea788a, title=2019 ISUOG实践指南：胎儿生物学和成长的超声评估, enTitle=ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth., guiderFrom=Ultrasound Obstet Gynecol. 2019 Jun;53(6):715-723., authorId=null, author=, summary=2019年6月，国际妇产科超声学会(ISUOG)发布了胎儿生物学和成长的超声评估指南，主要目的是为胎儿的生物学评估以及胎儿生长障碍的评估进行指导。 , cover=, journalId=null, articlesId=null, associationId=836, associationName=国际妇产科超声学会, associationIntro=国际妇产科超声学会（ISUOG）是一个专业的会员协会，在全世界124个国家拥有6450个会员，旨在通过提供和广泛传播最高质量的教育和研究信息，改善妇女卫生保健服务。, copyright=0, guiderPublishedTime=Sat Jun 08 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年6月，国际妇产科超声学会(ISUOG)发布了胎儿生物学和成长的超声评估指南，主要目的是为胎儿的生物学评估以及胎儿生长障碍的评估进行指导。 </div> <div><br> </div> 拓展指南：<strong>与<font color=red>胎儿超声</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=332b41c0013e0898" title="胎儿超声心动图操作指南和标准" target=_blank>胎儿超声心动图操作指南和标准</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=cd9371c0010512a5" title="2014 SOGC/CAR联合政策声明：胎儿超声检查的非医学应用(NO. 304)" target=_blank>2014 SOGC/CAR联合政策声明：胎儿超声检查的非医学应用(NO. 304)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=141211c000959968" title="2013 ISUOG实践指南：孕早期胎儿超声检查应用" target=_blank>2013 ISUOG实践指南：孕早期胎儿超声检查应用</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=9c8e11c000816036" title="2011 AIUM实践指南：胎儿超声心动图的表现" target=_blank>2011 AIUM实践指南：胎儿超声心动图的表现</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=158a21c0008159be" title="2011 ISUOG实践指南：孕期中三个月常规胎儿超声检查的表现" target=_blank>2011 ISUOG实践指南：孕期中三个月常规胎儿超声检查的表现</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E8%83%8E%E5%84%BF%E8%B6%85%E5%A3%B0" target=_blank>有关胎儿超声更多指南</a></ul>, tagList=[TagDto(tagId=91059, tagName=胎儿超声评估)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4462, appHits=314, showAppHits=6, pcHits=3105, showPcHits=1817, likes=88, shares=19, comments=11, approvalStatus=1, publishedTime=Thu Jun 13 23:12:30 CST 2019, publishedTimeString=2019-06-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jun 13 23:12:30 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 23:02:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ISUOG实践指南：胎儿生物学和成长的超声评估)])
2019 ISUOG实践指南：胎儿生物学和成长的超声评估
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1069931, encodeId=6f6b10699311c, content=谢谢啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:30:07 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069920, encodeId=e78f1069920fc, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:19:59 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008828, encodeId=31331008828cf, content=好全！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Tue Aug 17 21:30:40 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916152, encodeId=fdd1916152f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59415433265, createdName=青忧禾支, createdTime=Wed Jan 13 09:16:25 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804458, encodeId=dbb480445864, content=苦恼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:48:40 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
    2021-11-13 wrlssy

    谢谢啦！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1069931, encodeId=6f6b10699311c, content=谢谢啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:30:07 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069920, encodeId=e78f1069920fc, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:19:59 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008828, encodeId=31331008828cf, content=好全！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Tue Aug 17 21:30:40 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916152, encodeId=fdd1916152f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59415433265, createdName=青忧禾支, createdTime=Wed Jan 13 09:16:25 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804458, encodeId=dbb480445864, content=苦恼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:48:40 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
    2021-11-13 wrlssy

    谢谢！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1069931, encodeId=6f6b10699311c, content=谢谢啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:30:07 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069920, encodeId=e78f1069920fc, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:19:59 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008828, encodeId=31331008828cf, content=好全！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Tue Aug 17 21:30:40 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916152, encodeId=fdd1916152f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59415433265, createdName=青忧禾支, createdTime=Wed Jan 13 09:16:25 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804458, encodeId=dbb480445864, content=苦恼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:48:40 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
    2021-08-17 wrlssy

    好全！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1069931, encodeId=6f6b10699311c, content=谢谢啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:30:07 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069920, encodeId=e78f1069920fc, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:19:59 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008828, encodeId=31331008828cf, content=好全！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Tue Aug 17 21:30:40 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916152, encodeId=fdd1916152f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59415433265, createdName=青忧禾支, createdTime=Wed Jan 13 09:16:25 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804458, encodeId=dbb480445864, content=苦恼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:48:40 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
    2021-01-13 青忧禾支

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1069931, encodeId=6f6b10699311c, content=谢谢啦！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:30:07 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069920, encodeId=e78f1069920fc, content=谢谢！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Sat Nov 13 17:19:59 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008828, encodeId=31331008828cf, content=好全！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211113/7895119968f344f1b1854ae8a9ce7fad/c9580634e9e4450899057268c69ec436.jpg, createdBy=861b1485468, createdName=wrlssy, createdTime=Tue Aug 17 21:30:40 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916152, encodeId=fdd1916152f5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59415433265, createdName=青忧禾支, createdTime=Wed Jan 13 09:16:25 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804458, encodeId=dbb480445864, content=苦恼, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54125402667, createdName=ms7000001691666476, createdTime=Sat Jul 25 03:48:40 CST 2020, time=2020-07-25, status=1, ipAttribution=)]
    2020-07-25 ms7000001691666476

    苦恼

    0

以上为热门评论，梅斯医学App还有更多内容